Jane Street’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$516M Buy
12,087,991
+8,055,874
+200% +$437M 0.04% 292
2026
Q1
$253M Buy
4,032,117
+238,881
+6% +$19.1M 0.03% 330
2025
Q4
$362M Buy
3,793,236
+814,950
+27% +$79.9M 0.05% 235
2025
Q3
$291M Buy
2,978,286
+2,651,615
+812% +$275M 0.04% 274
2025
Q2
$35.1M Sell
326,671
-73,846
-18% -$7.47M 0.01% 992
2025
Q1
$40.4M Buy
400,517
+347,877
+661% +$35M 0.01% 796
2024
Q4
$4.7M Sell
52,640
-179,830
-77% -$15.8M ﹤0.01% 2741
2024
Q3
$19.5M Sell
232,470
-85,612
-27% -$6.75M ﹤0.01% 1257
2024
Q2
$24.5M Buy
318,082
+49,747
+19% +$3.64M 0.01% 1151
2024
Q1
$18.4M Sell
268,335
-147,516
-35% -$9.48M ﹤0.01% 1258
2023
Q4
$24M Buy
415,851
+171,491
+70% +$9.15M 0.01% 1123
2023
Q3
$12.9M Sell
244,360
-159,810
-40% -$8.38M ﹤0.01% 1510
2023
Q2
$21.9M Buy
404,170
+210,997
+109% +$11M 0.01% 1130
2023
Q1
$9.66M Buy
193,173
+52,013
+37% +$2.45M ﹤0.01% 1683
2022
Q4
$6.53M Sell
141,160
-193,373
-58% -$8.37M ﹤0.01% 2132
2022
Q3
$13M Buy
334,533
+121,247
+57% +$4.86M 0.01% 1457
2022
Q2
$7.95M Sell
213,286
-57,502
-21% -$2.34M ﹤0.01% 2015
2022
Q1
$12M Buy
270,788
+16,070
+6% +$696K ﹤0.01% 1759
2021
Q4
$10.8M Sell
254,718
-15,532
-6% -$653K ﹤0.01% 1797
2021
Q3
$11.7M Sell
270,250
-206,378
-43% -$9.13M ﹤0.01% 1606
2021
Q2
$20.4M Sell
476,628
-24,405
-5% -$1.03M 0.01% 1064
2021
Q1
$19.4M Sell
501,033
-589,655
-54% -$22.3M 0.01% 1003
2020
Q4
$39.2M Buy
1,090,688
+812,739
+292% +$29.3M 0.02% 536
2020
Q3
$10.6M Sell
277,949
-433,620
-61% -$16.7M 0.01% 1169
2020
Q2
$25M Buy
711,569
+532,173
+297% +$19.2M 0.02% 642
2020
Q1
$5.85M Buy
+179,396
New +$7.01M 0.01% 1066
2019
Q4
Sell
-81,370
Closed -$3.4M 5072
2019
Q3
$3.31M Buy
81,370
+42,745
+111% +$1.81M 0.01% 1313
2019
Q2
$1.66M Sell
38,625
-164,666
-81% -$6.33M ﹤0.01% 2084
2019
Q1
$7.8M Buy
203,291
+170,025
+511% +$6.49M 0.01% 830
2018
Q4
$1.18M Buy
33,266
+1,403
+4% +$50.9K ﹤0.01% 2337
2018
Q3
$1.23M Sell
31,863
-58,588
-65% -$2.05M ﹤0.01% 2500
2018
Q2
$2.96M Buy
90,451
+82,764
+1,077% +$2.5M 0.01% 1504
2018
Q1
$210K Sell
7,687
-56,680
-88% -$1.54M ﹤0.01% 4409
2017
Q4
$1.6M Buy
64,367
+44,704
+227% +$1.23M ﹤0.01% 1808
2017
Q3
$574K Buy
19,663
+10,233
+109% +$283K ﹤0.01% 2934
2017
Q2
$261K Sell
9,430
-44,783
-83% -$1.19M ﹤0.01% 3742
2017
Q1
$1.35M Buy
54,213
+38,814
+252% +$944K 0.01% 1743
2016
Q4
$333K Sell
15,399
-74,024
-83% -$1.62M ﹤0.01% 3254
2016
Q3
$2.13M Sell
89,423
-137,176
-61% -$3.27M 0.01% 1160
2016
Q2
$5.3M Buy
+226,599
New +$4.9M 0.03% 605
2016
Q1
Sell
-100,635
Closed -$1.77M 4061
2015
Q4
$1.86M Buy
+100,635
New +$1.8M 0.01% 1149
2015
Q3
Sell
-82,020
Closed -$1.45M 3583
2015
Q2
$1.45M Buy
82,020
+43,920
+115% +$785K 0.01% 1239
2015
Q1
$677K Buy
+38,100
New +$602K 0.01% 1736
2014
Q2
Sell
-26,632
Closed -$360K 2568
2014
Q1
$360K Buy
26,632
+16,626
+166% +$218K ﹤0.01% 1833
2013
Q4
$120K Sell
10,006
-84,986
-89% -$1M ﹤0.01% 2154
2013
Q3
$1.11M Sell
94,992
-14,138
-13% -$153K 0.01% 1030
2013
Q2
$1.01M Buy
+109,130
New +$926K 0.02% 902

Other funds holding BSX

Jane Street's BSX Position: Q2 2026 in Review

Jane Street increased its Boston Scientific (BSX) stake by 200% in Q2 2026, buying an estimated $437M and bringing the position to 12,087,991 shares worth $516M. The position accounts for 0.04% of the portfolio, ranked #292.

Jane Street first reported a position in BSX in Q2 2013 and has held it in 47 quarters since. 1,478 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Jane Street held 12,087,991 shares of Boston Scientific worth $516M as of Q2 2026.
  • Jane Street bought 8,055,874 Boston Scientific shares in Q2 2026, an estimated $437M.
  • Boston Scientific made up 0.04% of Jane Street's portfolio in Q2 2026, its #292 holding.
  • Jane Street first reported a position in Boston Scientific in Q2 2013 and has held it in 47 quarters since.
  • 1,478 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.